# New Animal Drugs in Genetically Engineered Animals; opAFP-GHc2 Recombinant Deoxyribonucleic Acid Construct
> **Food and Drug Administration** · Final rule. · Published 2015-11-24 · Effective 2015-11-24 · 80 FR 73104
## Document
- **Document number:** 2015-29902
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 80 FR 73104
- **CFR reference:** 21 CFR 510
- **Publication date:** 2015-11-24
- **Effective date:** 2015-11-24
- **HHS docket:** Docket No. FDA-2015-N-0002
## Abstract

The Food and Drug Administration (FDA, the Agency) is amending the animal drug regulations to reflect the approval of a new animal drug application (NADA) filed by AquaBounty Technologies, Inc. The NADA provides for use of a recombinant deoxyribonucleic acid (rDNA) gene construct in a lineage of genetically engineered Atlantic salmon.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2015/11/24/2015-29902/new-animal-drugs-in-genetically-engineered-animals-opafp-ghc2-recombinant-deoxyribonucleic-acid)
---
*AI Analytics · CC0 1.0*